您的位置: 首页 > 农业专利 > 详情页

DÉRIVÉ D'IMIDAZOLE DI-SUBSTITUÉ EN 1,4
专利权人:
Ltd.;Sumitomo Dainippon Pharma Co.
发明人:
BAN, Hitoshi,KUSAGI, Manabu,TOJO, Shingo,HASEGAWA, Futoshi,HASHIZUME, Miki
申请号:
EP16814361
公开号:
EP3312170A4
申请日:
2016.06.21
申请国别(地区):
EP
年份:
2018
代理人:
摘要:
The present invention provides a 1,4-disubstituted imidazole derivative of formula (1') wherein ring Q 1 is optionally-substituted C 6-10 aryl group, etc.; R 1 and R 2 are independently hydrogen atom, etc.; W 1 is optionally-substituted C 1-4 alkylene group; W 2 is -NR 3a C(O)- wherein R 3a is hydrogen atom or C 1-6 alkyl group, etc.; ring Q 2 is 5- to 10-membered heteroaryl group, etc.; W 3 is optionally-substituted C 1-4 alkylene group, etc.; n is 1, 2, 3, 4, or 5; R 4 is independently halogen atom, optionally-substituted C 1-6 alkyl group, etc.; R 5 is hydroxy group, etc.; and a pharmacologically acceptable salt thereof, which have a potent inhibitory effect on the sphere-forming capacity of cancer cells and are useful as an orally-available anti-tumor agent.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充